← Back to Screener
LeMaitre Vascular, Inc. (LMAT)
Price$111.65
Favorite Metrics
Price vs S&P 500 (26W)26.42%
Price vs S&P 500 (4W)-2.25%
Market Capitalization$2.59B
P/E Ratio (Annual)44.91x
Indicated Dividend Yield (Annual)0.87%
All Metrics
P/CF (Annual)31.91x
Book Value / Share (Quarterly)$17.28
P/TBV (Annual)5.10x
Indicated Dividend (Annual)$0.80
Revenue Growth (3Y)15.57%
Cash Flow / Share (Quarterly)$3.27
Payout Ratio (TTM)31.37%
Price vs S&P 500 (YTD)38.92%
Gross Margin (TTM)71.53%
Net Profit Margin (TTM)23.13%
EPS (TTM)$2.47
10-Day Avg Trading Volume0.18M
EPS Excl Extra (TTM)$2.47
Revenue Growth (5Y)14.04%
EPS (Annual)$2.52
Dividend / Share (Annual)$0.80
ROI (Annual)10.27%
Gross Margin (Annual)71.53%
Net Profit Margin (5Y Avg)17.78%
Cash / Share (Quarterly)$15.77
P/E Basic Excl Extra (TTM)44.91x
Revenue Growth QoQ (YoY)15.68%
EPS Growth (5Y)19.48%
P/E Normalized (Annual)44.91x
ROA (Last FY)9.38%
Revenue Growth TTM (YoY)13.53%
EBITD / Share (TTM)$3.16
ROE (5Y Avg)11.22%
Operating Margin (TTM)27.21%
Cash Flow / Share (Annual)$3.27
P/B Ratio6.59x
P/B Ratio (Quarterly)4.68x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)10.95x
Net Interest Coverage (TTM)17.33x
ROA (TTM)9.84%
EPS Growth QoQ (YoY)39.17%
EV / EBITDA (TTM)37.16x
EPS Incl Extra (Annual)$2.52
Current Ratio (Annual)12.89x
Quick Ratio (Quarterly)10.81x
3-Month Avg Trading Volume0.20M
52-Week Price Return37.04%
EV / Free Cash Flow (Annual)36.70x
P/E Incl Extra (TTM)44.91x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$15.83
P/S Ratio (Annual)10.39x
Asset Turnover (Annual)0.41x
52-Week High$118.01
Operating Margin (5Y Avg)22.02%
EPS Excl Extra (Annual)$2.52
CapEx CAGR (5Y)17.88%
Tangible BV CAGR (5Y)25.95%
26-Week Price Return30.41%
Quick Ratio (Annual)10.81x
13-Week Price Return36.96%
Total Debt / Equity (Annual)0.43x
Current Ratio (Quarterly)12.89x
Enterprise Value$2,733.034
Revenue / Share Growth (5Y)11.52%
Asset Turnover (TTM)0.43x
Book Value / Share Growth (5Y)15.47%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.05x
Pretax Margin (Annual)30.12%
Cash / Share (Annual)$15.77
3-Month Return Std Dev53.88%
Gross Margin (5Y Avg)67.27%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)16.83%
EBITDA Interim CAGR (5Y)12.56%
ROE (Last FY)14.67%
Net Interest Coverage (Annual)18.10x
EPS Basic Excl Extra (Annual)$2.52
P/FCF (TTM)34.82x
Receivables Turnover (TTM)7.84x
EV / Free Cash Flow (TTM)36.70x
Total Debt / Equity (Quarterly)0.43x
EPS Incl Extra (TTM)$2.47
Receivables Turnover (Annual)7.84x
ROI (TTM)10.71%
Dividend Growth Rate (5Y)16.13%
P/S Ratio (TTM)10.39x
Pretax Margin (5Y Avg)23.12%
Revenue / Share (Annual)$10.89
Tangible BV / Share (Annual)$15.83
Forward P/E38.46x
Free OCF CAGR (5Y)18.54%
Price vs S&P 500 (52W)7.21%
P/E Ratio (TTM)44.91x
EPS Growth TTM (YoY)27.88%
Year-to-Date Return41.57%
5-Day Price Return1.86%
EPS Normalized (Annual)$2.52
ROA (5Y Avg)8.37%
Net Profit Margin (Annual)23.13%
Month-to-Date Return5.17%
Cash Flow / Share (TTM)$1.64
EBITD / Share (Annual)$3.21
EPS Growth (3Y)39.48%
Operating Margin (Annual)27.21%
LT Debt / Equity (Annual)0.43x
P/CF (TTM)31.91x
ROI (5Y Avg)9.47%
P/E Excl Extra (TTM)44.91x
LT Debt / Equity (Quarterly)0.43x
EPS Basic Excl Extra (TTM)$2.47
P/TBV (Quarterly)5.10x
Payout Ratio (Annual)31.37%
P/B Ratio (Annual)4.68x
Dividend / Share (TTM)$0.80
Inventory Turnover (TTM)1.05x
Pretax Margin (TTM)30.12%
Book Value / Share (Annual)$17.28
Price vs S&P 500 (13W)36.27%
Net Margin Growth (5Y)7.15%
Dividend Yield (TTM)0.70%
Beta0.66x
P/FCF (Annual)34.82x
Revenue / Share (TTM)$10.87
ROE (TTM)15.58%
52-Week Low$78.01
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.94
3.94
3.94
4.00
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
LMATLeMaitre Vascular, Inc. | 10.39x | 14.04% | 71.53% | 27.21% | $111.65 |
SYKStryker Corporation | 5.15x | 11.84% | 64.57% | 19.43% | $338.38 |
BSXBoston Scientific Corp. | 4.76x | 15.16% | 69.01% | 18.00% | $63.42 |
MMM3M Company | 3.18x | -4.97% | 39.92% | 18.55% | $150.55 |
MDLNMedline Inc. Class A common stock | 2.21x | — | 26.44% | 7.78% | $46.94 |
BDXBecton, Dickinson and Co. | 2.01x | 6.32% | 46.42% | 12.15% | $154.82 |
RMDResMed Inc. | 6.06x | 11.72% | 60.85% | 33.70% | $224.72 |
DXCMDexCom, Inc. | 5.23x | 19.33% | 62.09% | 19.56% | $61.23 |
WSTWest Pharmaceutical Services, Inc. | 6.22x | 7.44% | 35.91% | 19.03% | $269.81 |
PODDInsulet Corporation | 5.31x | 24.53% | 71.63% | 12.92% | $201.47 |
PENPenumbra, Inc. | 9.31x | 20.16% | 67.14% | 13.48% | $331.47 |
About
LeMaitre Vascular manufactures and distributes medical devices for treating peripheral vascular disease during open surgery, with primary revenue from lower extremity and carotid product lines. Its portfolio includes angioscopes, balloon catheters, vascular grafts, vessel closure systems, and related surgical devices. The company also processes and cryopreserves human tissues for implantation.